Home | 21 Days | 04 | 05 | 06 | 07 | 08 | 09 | 10 | 11
By Christian Hoffmann &
Bernd S. Kamps
31 July
- Body Mass Index and Risk for Intubation or Death in SARS-CoV-2 Infection
- Activation and evasion of type I interferon responses by SARS-CoV-2
- Epidemiology of invasive pulmonary aspergillosis among COVID-19 intubated patients: a prospective study
30 July
- Comparison of Face-Touching Behaviors Before and During the Coronavirus Disease 2019 Pandemic
- Papain-like protease regulates SARS-CoV-2 viral spread and innate immunity
- Assessment of Community-Level Disparities in Coronavirus Disease 2019 (COVID-19) Infections and Deaths in Large US Metropolitan Areas
29 July
- SARS-CoV-2-reactive T cells in healthy donors and patients with COVID-19 (Nature)
- Evaluation of the mRNA-1273 Vaccine against SARS-CoV-2 in Nonhuman Primates (N Engl J Med)
- Case characteristics, resource use, and outcomes of 10 021 patients with COVID-19 admitted to 920 German hospitals: an observational study (Lancet Respir Med )
28 July
- Longitudinal analyses reveal immunological misfiring in severe COVID-19
- Estimation of Viral Aerosol Emissions From Simulated Individuals With Asymptomatic to Moderate Coronavirus Disease 2019
- Outcomes of Cardiovascular Magnetic Resonance Imaging in Patients Recently Recovered From Coronavirus Disease 2019 (COVID-19)
27 July
- Symptom Duration and Risk Factors for Delayed Return to Usual Health Among Outpatients with COVID-19 in a Multistate Health Care Systems Network
- Patients with immune-mediated inflammatory diseases receiving cytokine inhibitors have low prevalence of SARS-CoV-2 seroconversion
- Evidence of exposure to SARS-CoV-2 in cats and dogs from households in Italy
26 July
Today, revise what you have studied over the past months. A summary of articles about clinical manifestations, comorbidities and severe COVID-19 since the beginning.
25 July
- Structural basis of RNA cap modification by SARS-CoV-2
- COVID-19: immunopathogenesis and Immunotherapeutics
- Particle sizes of infectious aerosols: implications for infection control
24 July
- 4th Edition: Covid Reference España
- Investigation of a superspreading event preceding the largest meat processing
23 July
- Potent neutralizing antibodies directed to multiple epitopes on SARS-CoV-2 spike
- Virus-host interactome and proteomic survey of PBMCs from COVID-19 patients reveal potential virulence factors influencing SARS-CoV-2 pathogenesis
- The Contribution of the Age Distribution of Cases to COVID-19 Case Fatality Across Countries – A 9-Country Demographic Study
- Retrospective Multicenter Cohort Study Shows Early Interferon Therapy Is Associated with Favorable Clinical Responses in COVID-19 Patients
22 July
- Historically controlled comparison of glucocorticoids with or without tocilizumab versus supportive care only in patients with COVID-19-associated cytokine storm syndrome: results of the CHIC study
- Distinct conformational states of SARS-CoV-2 spike protein
- Feasibility of Separate Rooms for Home Isolation and Quarantine for COVID-19 in the United States
21 July
- Outcomes of COVID-19 in Patients with CLL: A Multicenter, International Experience
- Thrombosis in Hospitalized Patients With COVID-19 in a New York City Health System
- The impact of the COVID-19 pandemic on cancer deaths due to delays in diagnosis in England, UK: a national, population-based, modelling study
20 July
- Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial.
- Immunogenicity and safety of a recombinant adenovirus type-5-vectored COVID-19 vaccine in healthy adults aged 18 years or older: a randomised, double-blind, placebo-controlled, phase 2 trial.
- Clinical Manifestations and Outcomes of Critically Ill Children and Adolescents with COVID-19 in New York City
19 July
- Kind request to authors of scientific papers
18 July
- Dexamethasone in Hospitalized Patients with Covid-19 — Preliminary Report
- Structural basis for translational shutdown and immune evasion by the Nsp1 protein of SARS-CoV-2
- The impact of mutations in SARS-CoV-2 spike on viral infectivity and antigenicity
17 July
- Universal Masking to Prevent SARS-CoV-2 Transmission—The Time Is Now
- Magnitude and kinetics of anti-SARS-CoV-2 antibody responses and their relationship to disease severity
- Aging immunity may exacerbate COVID-19
16 July
- An mRNA Vaccine against SARS-CoV-2 – Preliminary Report
- Deep immune profiling of COVID-19 patients reveals distinct immunotypes with therapeutic implications
- Physical distancing interventions and incidence of coronavirus disease 2019: natural experiment in 149 countries
15 July
Today, there will be no Top 10, but the Top 1,000:
We dedicate this book to our students. May this selection of approx. 1,000 fine articles and full-text links deepen their understanding of the new coronavirus and prepare them for the challenges ahead (PDF, 390 pages).
Download PDF (390 pages)
14 July
- Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients.
- Structural basis of a shared antibody response to SARS-CoV-2
- Potential impact of the COVID-19 pandemic on HIV, tuberculosis, and malaria in low-income and middle-income countries: a modelling study
13 July
- Cardiac manifestations in COVID-19 patients – A systematic review
- Types of Assays for SARS-CoV-2 Testing: A Review
- Decontamination and reuse of N95 filtering facemask respirators: a systematic review of the literature
- That Escalated Quickly: Remdesivir’s Place in Therapy for COVID-19
12 July
- Characteristics of Persons Who Died with COVID-19 — United States
- Blood cell counts and lymphocyte subsets of patients admitted during the COVID-19 pandemic
- The inside story of the RECOVERY trial
11 July
- Persistent Symptoms in Patients After Acute COVID-19 (Jama)
- Immunophenotyping of COVID-19 and influenza highlights the role of type I interferons in development of severe COVID-19 (Science Immunology)
- Coagulation disorder in COVID-19 (Lancet Immunology)
10 July
- COVID-19: the worst may be yet to come
- Pandemic peak SARS-CoV-2 infection and seroconversion rates in London frontline health-care workers
- Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein
9 July
- The emerging spectrum of COVID-19 neurology: clinical, radiological and laboratory findings
- Coronavirus disease among persons with sickle cell disease
- California’s San Quentin prison declined free coronavirus tests and urgent advice — now it has a massive outbreak
- Potential transmission of SARS-CoV-2 on a flight from Singapore to Hanghzou, China
- OpenSAFELY: factors associated with COVID-19 death in 17 million patients
8 July
- Coronavirus disease exposure and spread from nightclubs, South Korea
- Kinetics of viral load and antibody response in relation to COVID-19 severity
- COVID-19 Among Workers in Meat and Poultry Processing Facilities
7 July
- It is Time to Address Airborne Transmission of COVID-19
- Human IgG neutralizing monoclonal antibodies
- Developing a SARS-CoV-2 Vaccine at Warp Speed
- Seroprevalence of SARS-CoV-2 Among Frontline Healthcare Personnel
- Obesity and COVID-19 in New York City
6 July
- SARS-CoV-2 seroprevalence in COVID-19 hotspots
- COVID-19 and arterial hypertension
- Interleukin-6 blockade with sarilumab
5 July
- Comparing SARS-CoV-2 with SARS-CoV and influenza pandemics
- Exaggerated risk of transmission of COVID-19 by fomites
- Asymptomatic SARS-CoV-2 infection in Belgian long-term care facilities
4 July
- Primary exposure to SARS-CoV-2 protects against reinfection in rhesus macaques
- Stability of SARS-CoV-2 and other coronaviruses in the environment and on common touch surfaces and the influence of climatic conditions: a review
- COVID-19 in health-care workers in three hospitals in the south of the Netherlands: a cross-sectional study
- Evolution of Altered Sense of Smell or Taste in Patients With Mildly Symptomatic COVID-19
3 July
Among other topics, how to safely reopen colleges and universities during COVID-19¸ screening for SARS-CoV-2 infection within a psychiatric hospital; virolactia in an asymptomatic mother; impact of for SARS-CoV-2 viral load on risk of intubation and mortality among hospitalized patients with coronavirus disease 2019; and high proportion of asymptomatic SARS-CoV-2 infections in 9 long-term care facilities.
2 July
Among other topics, Next Generation Sequencing of T and B cell receptor repertoires; excess deaths from COVID-19 and other causes; protracted ketonaemia in hyperglycaemic emergencies; neurologic and radiographic findings associated with COVID-19 infection in children; and is a “cytokine storm” relevant to COVID-19?
1 July
Bouhaddou M, Memon DF, Meyer B, et al. The Global Phosphorylation Landscape of SARS-CoV-2 Infection. Cell June 28, 2020.
Nothing to do next weekend? Then read this incredible work of 66 pages (> 400 references!). In brief: proteomics approaches that globally quantify changes in protein abundance and phosphorylation represent a powerful tool to elucidate mechanisms of viral pathogenesis by providing a snapshot of how cellular pathways and processes are rewired upon infection. Using a quantitative mass spectrometry-based phosphoproteomics survey of SARS-CoV-2 infection in Vero E6 cells, the 78 (!) authors present the global phosphorylation and protein abundance landscape of SARS-CoV-2 infection, map phosphorylation changes to disrupted kinases and pathways, and use these profiles to find drugs with the potential to treat SARS-CoV-2 infection. In total, 87 compounds (10 FDA-approved drugs) were identified.